Clinical Trials on Health in Germany

Total 5870 results

Boehringer Ingelheim

Terminated

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of Single Escalating Doses of BI 1034020 Administered Intravenously or Subcutaneously to Male Healthy Volunteers

Healthy

Germany
Teva Pharmaceuticals USA

Completed

Medroxyprogesterone Acetate Injection 150 mg/1 mL in Postmenopausal Women

Healthy

Germany
University of Jena

Unknown

PCR-Based Detection of Bacterial Agents in Platelet Concentrates and Whole Blood

Healthy

Germany
Technical University of Munich

Unknown

EEG and Auditory Evoked Potentials During Local Anesthesia

Healthy

Germany
Boehringer Ingelheim

Completed

A Study in Healthy Men to Test How Different Doses of BI 3000202 Are Tolerated and How Food Influences the Amount of BI 3000202 in the Blood

Healthy

Germany
Boehringer Ingelheim

Completed

A Study in Healthy Men to Test How Esomeprazole Influences the Amount of BI 1819479 in the Blood

Healthy

Germany
Charite University, Berlin, Germany

Completed

Mechanism of tDCS-induced Learning Enhancement - the Role of Serotonin (LESO)

Healthy Young and Older Adults

Germany
Boehringer Ingelheim

Completed

A Study to Test How Well Healthy Men Tolerate Different Doses of BI 764198

Healthy

Germany
Samsung Bioepis Co., Ltd.

Completed

Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of SB4 in Healthy Male Subjects

Healthy

Germany
Boehringer Ingelheim

Completed

This Study Tests How Different Doses of BI 690517 Are Taken up in the Body of Healthy Men. The Study Also Looks at How Food Influences the Amount of BI 690517 in the Blood

Healthy

Germany
Boehringer Ingelheim

Completed

Drug-drug Interaction Trial of BI 113608 in Combination With Ketoconazole and Voriconazole in Healthy Male Subjects

Healthy

Germany
Boehringer Ingelheim

Completed

Safety, Tolerability, and Pharmacokinetics of Multiple Rising Doses of BI 425809 Tablets for 12 Days to Young and Elderly Healthy Male and Female Volunteers and Comparison of Pharmacokinetics of a Single Oral Dose of BI 425809 (Morning Versus Evening)

Healthy

Germany
Boehringer Ingelheim

Completed

Investigation of Drug-drug Interaction of Nintedanib and Ketoconazole in Healthy Male Volunteers

Healthy

Germany
Boehringer Ingelheim

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses and Effect of Food on the Bioavailability of BI 1060469

Healthy

Germany
UCB BIOSCIENCES GmbH
Schwarz BioSciences GmbH; Alfred-Nobel-Str. 10; 40789 Monheim am Rhein

Completed

Study to Evaluate the Pharmacokinetics (PK), Safety, Tolerability of Single-Dose Transdermal Rotigotine in Japanese and Caucasian Healthy Male / Female Subjects

Healthy

Germany
Boehringer Ingelheim

Completed

Drug Interaction Study With Dabigatran Etexilate and Dronedarone in Healthy Subjects

Healthy

Germany
Astellas Pharma Europe B.V.

Completed

A Study to Compare How Much Solifenacin Succinate and Mirabegron Reach the Blood When Administered Together as Fixed-dose Combination Tablets and With Single Individual Tablets of the Same Medications at Three Dose Levels

Healthy Subjects | Bioavailability | Phase 1

Germany
Boehringer Ingelheim

Completed

Investigation of Pharmacodynamic Effects of Dabigatran and Ticagrelor and Assessment of Ticagrelor Interaction Potential With Dabigatran

Healthy

Germany
Pascoe Pharmazeutische Praeparate GmbH

Completed

Pharmacological Effects of Neurapas® Balance and Pascoflair® 425 mg on Brain Activity in Healthy Volunteers (NCAG 5209)

Healthy

Germany
Novartis

Completed

A Study to Compare Ocular Safety and Tolerability of Prednisolone Acetate 0.5% Eye Drops Versus Vehicle in Healthy Volunteers

Healthy

Germany
University Hospital, Bonn

Active, not recruiting

Multi-level Molecular Profiling of High Acute Stress: a Clinical Study

Healthy

Germany
Merck KGaA, Darmstadt, Germany

Completed

Relative Bioavailability of Two Tepotinib Film-Coated Tablet Formulations in Healthy Volunteers

Healthy

Germany
Boehringer Ingelheim

Terminated

This Study in Healthy Volunteers Determines the Amount of BI 730460 in the Blood When Taken as Tablet. It Looks at How Different Doses of BI 730460 Are Taken up in the Body and How Well They Are Tolerated. The Study Also Tests How Food Influences the Amount of BI 730460 in the Blood.

Healthy

Germany
Universitätsklinikum Hamburg-Eppendorf

Withdrawn

Investigation of Gender Specificity of the Effects of Furosemide in Healthy Female and Male Volunteers

Healthy Male and Female Volunteers

Germany
Boehringer Ingelheim

Completed

A Study in Healthy Men and Women to Test Which Effects Donepezil and BI 425809 Have on Each Other

Healthy

Germany
Boehringer Ingelheim

Completed

To Investigate the Safety, Tolerability, Pharmacokinetics and the Relative Bioavailability of BI 1026706

Healthy

Germany
Idorsia Pharmaceuticals Ltd.

Completed

First-in-man Study of Single Ascending Dose of a New Drug for Neurological Disorders

Healthy Subjects

Germany
Idorsia Pharmaceuticals Ltd.

Completed

First-in-man Study of Single and Multiple Ascending Doses of a New Drug for Neurological Disorders

Healthy Subjects

Germany
Heinrich-Heine University, Duesseldorf

Completed

Effects of Acute Red Raspberry Consumption on Vascular Function in Healthy Individuals

Healthy

Germany
Boehringer Ingelheim

Completed

To Assess Safety, Tolerability and Pharmacokinetics of BI 416970 in Healthy Male Volunteers

Healthy

Germany
Boehringer Ingelheim

Completed

Investigation of Food Effect and Gastric ph Increase on the Bioavailability of Faldapravir

Healthy

Germany
Boehringer Ingelheim

Completed

to Evaluate Effect of Multi Doses Flibans 100 mg Film-c Tablets on Single Dose PK of Digoxin 0.5 mg, Healthy Volunteers

Healthy

Germany
University Medicine Greifswald

Completed

Acceptance and Efficacy of a Digital Application Among Parents to Control Early Childhood Caries (FU-APP)

Oral Hygiene | Oral Health | Early Childhood Caries

Germany
Novo Nordisk A/S

Completed

A Research Study Investigating How Semaglutide and Dapagliflozin Act in Your Body When Dosed in One Tablet

Healthy Volunteers

Germany
BioVersys SAS

Completed

Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics of BV100 in Male Subjects

Healthy Subjects

Germany
Orion Corporation, Orion Pharma

Completed

Dose-finding Pharmacokinetic Study in Healthy Males (COMDOS1)

Healthy Volunteers

Germany
University of Jena

Completed

Effects of Soluble Phosphate in Humans

Healthy Volunteers

Germany
University Hospital, Bonn

Completed

The Influence of Glutamate on Memory in Humans

Healthy Individuals

Germany
BioVersys SAS
Nuvisan GmbH

Completed

Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics of BV100 in Healthy Male Subjects

Healthy Volunteers

Germany
GlaxoSmithKline
Biomedical Advanced Research and Development Authority

Terminated

Effects of GSK2798745 on Alveolar Barrier Disruption in a Segmental Lipopolysaccharide (LPS) Challenge Model

Healthy Volunteers

Germany
Clemens von Schacky
Südbayerische Fleischwaren GmbH

Completed

Influence of Dietary Omega-3 Fatty Acids in Various triOMEG Sausages on the HS-Omega-3 Index in Healthy Individuals

Healthy Volunteers

Germany
Max Planck Institute for Human Cognitive and Brain...
University of Leipzig

Unknown

Serotonin and Motor Plasticity

Healthy Controls

Germany
Philipps University Marburg Medical Center

Completed

The Role of Expectations in Experimentally Induced Sadness

Healthy Participants

Germany
Winfried Rief

Completed

Pharmacological Conditioning of Sleep Patterns in Healthy Participants Using Amitriptylin

Healthy Participants

Germany
University of Jena

Completed

Combination of Probiotic and Calcium in Healthy Adults

Healthy Subjects

Germany
University of Jena

Completed

Human Intervention Study With Calcium Phosphate and Vitamin D

Healthy Subjects

Germany
Max-Planck-Institute of Psychiatry
Dr. Kade/Besins Pharma GmbH, Rigistr. 2, 12277 Berlin

Completed

Progesterone Reduces Wakefulness in Sleep EEG and Has no Effect on Cognition in Healthy Postmenopausal Women

Healthy | Postmenopausal

Germany
Boehringer Ingelheim

Recruiting

A Study in Healthy Men to Test How Different Doses of BI 3031185 Are Tolerated and How Food Influences the Amount of BI 3031185 in the Blood

Healthy

Germany
Boehringer Ingelheim

Completed

A Study in Healthy Men to Test How the Body Takes up and Tolerates Different Doses of BI 474121, and Whether it Makes a Difference if BI 474121 is Taken as a Tablet or a Drink.

Healthy

Germany
Boehringer Ingelheim

Terminated

A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood

Healthy

Germany

3

Subscribe